Mersana Therapeutics【MRSN】株式ニュース

名称	銘柄コード	市場	種別
Mersana Therapeutics Inc	MRSN	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.00	0.00%	2.38	04:13:19

始値	安値	高値	終値	前日終値
2.38	2.27	2.42		2.38

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/22	21:00	GLOBE	Mersana Therapeutics to Present at Upcoming Investor..
2024/5/17	21:26	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/5/10	13:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2024/5/10	06:06	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/5/09	22:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/09	20:10	EDGAR2	Form 8-K - Current report
2024/5/09	19:59	GLOBE	Mersana Therapeutics Provides Business Update and..
2024/5/04	05:30	GLOBE	Mersana Therapeutics Announces Inducement Grants Under..
2024/5/02	21:00	GLOBE	Mersana Therapeutics to Host First Quarter 2024 Conference..
2024/4/05	05:30	GLOBE	Mersana Therapeutics Announces Inducement Grants Under..
2024/2/29	06:08	EDGAR2	Form 8-K - Current report
2024/2/29	06:07	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/29	06:05	EDGAR2	Form POS AM - Post-Effective amendments for registration..
2024/2/28	22:49	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/28	22:43	EDGAR2	Form POSASR - Post-effective Amendment to an automatic shelf..
2024/2/28	21:07	EDGAR2	Form 8-K - Current report
2024/2/28	21:00	GLOBE	Mersana Therapeutics Provides Business Update and..
2024/2/27	22:01	GLOBE	Mersana Therapeutics to Present at Upcoming Investor..
2024/2/21	22:00	GLOBE	Mersana Therapeutics to Host Fourth Quarter and Year End..
2024/2/15	10:56	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/15	10:43	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/2/14	23:20	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/01	22:00	GLOBE	Mersana Therapeutics to Participate in Guggenheim’s 6th..
2024/1/18	07:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/18	07:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/18	07:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/18	07:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/18	07:18	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/18	07:18	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/18	07:16	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/17	11:14	EDGAR2	Form 144 - Report of proposed sale of securities
2024/1/17	11:13	EDGAR2	Form 144 - Report of proposed sale of securities
2024/1/17	11:13	EDGAR2	Form 144 - Report of proposed sale of securities
2024/1/13	06:42	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2024/1/05	22:06	EDGAR2	Form 8-K - Current report
2024/1/05	22:01	GLOBE	Mersana Therapeutics Announces Business Updates, Expected..
2024/1/05	06:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/22	06:11	EDGAR2	Form 8-K - Current report
2023/12/02	06:30	GLOBE	Mersana Therapeutics Announces Inducement Grants Under..
2023/11/07	22:42	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07	21:18	EDGAR2	Form 8-K - Current report
2023/11/07	21:00	GLOBE	Mersana Therapeutics Provides Business Update and Announces..
2023/11/01	05:30	GLOBE	Mersana Therapeutics to Host Third Quarter 2023 Conference..
2023/11/01	01:59	DJN	Mersana Therapeutics Shares Rise 8% After FDA Lifts Clinical..
2023/10/31	22:07	DJN	Mersana Says FDA Lifts Clinical Hold on Gastric-Cancer..
2023/10/31	21:12	EDGAR2	Form 8-K - Current report
2023/10/31	21:00	GLOBE	Mersana Therapeutics Announces FDA has Lifted Clinical Hold..
2023/10/28	05:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/10/05	05:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/10/05	05:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..